Anavex publishes study showing blarcamesine prevents cognitive decline – Longevity.Technology
Anavex announced the publication of a peer-reviewed study in Neuroscience Letters, showing that pre-treatment with blarcamesine prevented amyloid-beta–induced memory impairment
Superpower launches $199 membership for concierge-level preventive care – Longevity.Technology
Superpower launched a $199-per-year membership aimed at bringing concierge-level preventive healthcare to a broader audience, according to the company. The
AutoPhagyGO is harnessing autophagy to redefine healthy aging
Japanese XPRIZE semifinalist draws on Nobel-winning science and lifestyle heritage to push healthspan innovation beyond the lab. In partnership with
DiamiR biosciences secures New York approval for APOE genotyping test – Longevity.Technology
DiamiR Biosciences and Aptorum Group announced that New York State granted Clinical Laboratory Evaluation Program (CLEP) approval for DiamiR’s APOE
Life Time disrupts sleep market with LTH Dream melatonin-free formula – Longevity.Technology
Life Time has launched a new sleep-support product called LTH Dream, aiming to stand out in a market dominated by
NIA funds trial of Alzheimer’s drug targeting oral health bacteria
Lighthouse Pharma lands major grant funding to advance Alzheimer’s drug into Phase 2 trial in patients with P gingivalis. US
Determining optimal protein intake from data, not dogmatism
Tension has been brewing in the world of nutrition. The subject of the dispute? Protein—or more precisely, protein requirements, and
#362 ‒ Understanding anxiety: defining, assessing, and treating health anxiety, OCD, and the spectrum of anxiety disorders | Josh Spitalnick, Ph.D., A.B.P.P.
Josh Spitalnick is a clinical and research psychologist with expertise in treating a variety of anxiety conditions with cognitive-behavioral therapy
OpenAI sheds new light on longevity research
Cellular reprogramming research collab with Retro Bio produced Yamanaka variants that may be more effective at reversing DNA damage. Earlier
Are you in the right industry?
ARDD presentation addresses the need for consensus on the term we use to describe our industry. The Aging Research &
Life Bio: epigenetic rejuvenation ‘transcends organs’
Longevity biotech presents data demonstrating therapeutic impact of partial epigenetic reprogramming across multiple biological systems. Today at the Aging Research
Lighthouse pharmaceuticals wins $49.2 million NIA grant for Alzheimer’s trial – Longevity.Technology
Lighthouse Pharmaceuticals received a $49.2 million grant from the National Institute on Aging (NIA) to support a Phase 2 clinical